Radwa Mahmoud | Biotechnology | Excellence in Research Award

Ms. Radwa Mahmoud | Biotechnology | Excellence in Research Award

Biotechnology Department, Faculty of Science, Cairo University, Egypt

Ms. Radwa Mahmoud is an emerging biotechnology researcher with strong expertise in cancer therapeutics, molecular diagnostics, and nanoparticle biosynthesis. She is currently pursuing a Master’s degree in Biotechnology at Cairo University, where she previously completed her Bachelor’s degree with distinction, ranking among the top students. Her research interests span breast cancer treatment using scorpion-venom-derived peptides, CRISPR-based microbiome engineering, antimicrobial peptides, and the biomedical applications of nanomaterials. Radwa has extensive hands-on experience in wet-lab experimentation, diagnostic assay design, cytotoxicity analysis, molecular cloning, protein purification, and computational modeling. She has led multidisciplinary research projects focused on early breast cancer detection and innovative therapeutic models, earning competitive funding support from the Science and Technology Development Fund (STDF) and winning awards such as Best Poster at SOLE and a Silver Medal at the international iGEM competition. Her professional experience includes roles in pharmaceutical research and development, molecular biology laboratories, and academic teaching support. Radwa’s growing publication record and contributions to translational research highlight her commitment to advancing oncology, biotechnology innovation, and therapeutic discovery. She aims to continue developing impactful scientific solutions addressing global health challenges.

Profiles: Scopus | Orcid

Featured Publications

Amen, R.A. (2024). “Harnessing plant extracts for skin health and dermatological care: herbal wonders green solutions” in Herbal Wonders Green Solutions.

Amen, R.A. (2024). “Therapeutic potential and characteristics of Smp43 peptide (scorpion venom) and its interaction with cellular signaling pathways: a review” in Review.

Amen, R.A. (2024). “Exploring the potential of natural compounds in cancer treatment: a review” in Review.

Amen, R.A. (2024). “Coinfection of schistosomiasis and hepatitis C in Egypt: challenges and possible management strategies” in Review.

Amen, R.A. (2024). “Biosynthesis of silver, copper, and their bi-metallic nanocomposites by Staphylococcus aureus: their antimicrobial, anticancer activity, and cytotoxicity effect” in Journal Article.

Amen, R.A. (2023). “COVID-19 omicron variant: variation from other variants, immune response, and vaccination against this rapidly spreading pandemic” in Review.

Amen, R.A. (2022). “Pharmacological properties of 4′, 5, 7-trihydroxyflavone (apigenin) and its impact on cell signaling pathways” in Review.

Assist. Prof. Dr. Xiancai Li | Natural Products Chemistry | Research Excellence Award

Assist. Prof. Dr. Xiancai Li | Natural Products Chemistry | Research Excellence Award

South China Botanical Garden, Chinese Academy of Sciences, China

Assist Prof. Dr. Xiancai Li is a dedicated pharmacological researcher recognized for his strong contributions to plant-based therapeutic discovery, particularly in the antimicrobial and uric-acid-lowering potential of natural products. With extensive experience in molecular biology and phytochemical research, he has developed deep expertise in transcriptomic and metabolomic analysis, enabling him to elucidate complex biochemical pathways and identify novel bioactive compounds. He earned his Bachelor of Science in plant protection, followed by a Ph.D. in science, where he focused on natural product pharmacology and plant-derived mechanisms of disease mitigation. His postdoctoral research at the Institute of Genetics and Developmental Biology further strengthened his proficiency in functional genomics and biological validation techniques, leading to several impactful publications in reputable scientific journals. Currently serving as a Research Associate at the South China Botanical Garden, Chinese Academy of Sciences, he continues to advance innovative pharmacological studies with an emphasis on plant resources for drug discovery. His research interests span antimicrobial resistance, metabolic regulation, phytotherapy, and natural product innovation. Throughout his career, he has been recognized with academic honors and research achievements that highlight his commitment to scientific excellence. Dr. Li remains dedicated to advancing evidence-based natural medicine and contributing to global health solutions.

Profile: Orcid

Featured Publications

Li, X., Yu, W., Yao, L., Liu, F., Li, Y., Xiong, B., Xie, J., & Qiu, S.-X. (2026). “Amelioration effects of Cajanus cajan extracts and the active ingredient pinostrobin on hyperuricemia and related kidney injury.” Food & Function.
https://doi.org/10.1039/D5FO01806D

Li, X., Chen, S., Wu, Y., Liu, F., Jumai, A., Zhu, B., Xiong, B., & Qiu, S.-X. (2026). “γ-mangostin from Garcinia mangostana (L.) exerts antifungal activity against Cryptococcus neoformans by inhibiting ribosome biogenesis.” Journal of Ethnopharmacology, March 2026. https://doi.org/10.1016/j.jep.2025.120986